This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): MTR-108, MTR 108, MTR108
Description: Raviclust (MTR-108) contains S-ethylisothiouronium diethylphosphate, a Nitric Oxide Synthase (NOS) inhibitor, that is administered as a fast-acting nasal spray.
Additional information available to subscribers only: